1st gene therapy for deafness approved by FDA
Digest more
The Breakthrough Prize Foundation awarded researchers involved in developing gene therapies for blindness and sickle cell ...
Pharmaceutical Technology on MSN
FDA shares guide on genome editing best practices
This guidance emphasises the potential of NGS methods in mitigating safety risks associated with therapies incorporating genome editing.
Qatar has taken a landmark step in precision medicine after Sidra Medicine became the first hospital in the country — and one ...
The global gene therapy market size is projected to expand significantly, with an estimated value of USD 19.3 billion by 2034 ...
GlobalData on MSN
MSD-backed Ray locks in $125m to back eye drug pipeline
The MSD and Novo Holdings-backed Series B will shed light on the potential of Ray’s vision restoration treatment pipeline.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results